The abstract is read at the publisher; the summary is JClub's.
HLF is restricted to the most primitive quiescent basal cell state in lung epithelium, and its silencing in LUSC is linked to poor survival.
- Why it matters: LUSC lacks oncogene-directed therapies despite frequent TP53 mutations and RB pathway disruption, and the field needs a quiescence-linked regulatory vulnerability.
- What they did: Single-cell transcriptomics mapped four basal states along a quiescence-to-activation gradient; in primary LUSC tumors, HLF was silenced across six genetically distinct tumors with promoter hypermethylation, and DREAM target genes were de-repressed.
- The result: Re-expressing HLF reinstated G0 quiescence and suppressed proliferation in basal stem cells, LUSC cell lines, and patient-derived tumor organoids, preferentially repressing DREAM targets and doing so independently of p53 status.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.